HK1168423A1 - 多發性硬化的診斷 - Google Patents

多發性硬化的診斷

Info

Publication number
HK1168423A1
HK1168423A1 HK12109281.5A HK12109281A HK1168423A1 HK 1168423 A1 HK1168423 A1 HK 1168423A1 HK 12109281 A HK12109281 A HK 12109281A HK 1168423 A1 HK1168423 A1 HK 1168423A1
Authority
HK
Hong Kong
Prior art keywords
diagnosis
multiple sclerosis
sclerosis
Prior art date
Application number
HK12109281.5A
Other languages
English (en)
Inventor
霍華德．
．韋納
艾潤．
．科恩
弗朗西斯科．
．昆塔納
Original Assignee
耶達研究與發展有限公司
伯萊翰女子醫院公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 耶達研究與發展有限公司, 伯萊翰女子醫院公司 filed Critical 耶達研究與發展有限公司
Publication of HK1168423A1 publication Critical patent/HK1168423A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK12109281.5A 2008-11-12 2012-09-20 多發性硬化的診斷 HK1168423A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11364508P 2008-11-12 2008-11-12
PCT/IL2009/001066 WO2010055510A2 (en) 2008-11-12 2009-11-12 Diagnosis of multiple sclerosis

Publications (1)

Publication Number Publication Date
HK1168423A1 true HK1168423A1 (zh) 2012-12-28

Family

ID=42170484

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12109281.5A HK1168423A1 (zh) 2008-11-12 2012-09-20 多發性硬化的診斷

Country Status (8)

Country Link
US (1) US9267945B2 (zh)
EP (1) EP2353004B1 (zh)
JP (1) JP2012508865A (zh)
CN (1) CN102388307B (zh)
AU (1) AU2009315230A1 (zh)
CA (1) CA2743590A1 (zh)
HK (1) HK1168423A1 (zh)
WO (1) WO2010055510A2 (zh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140105980A1 (en) 2012-10-11 2014-04-17 Uti Limited Partnership Methods and compositions for treating multiple sclerosis and related disorders
EP3421487B1 (en) 2010-10-19 2023-06-28 The Regents of the University of Colorado, a body corporate Peptides for modulating t-cell activity and uses thereof
US9511151B2 (en) 2010-11-12 2016-12-06 Uti Limited Partnership Compositions and methods for the prevention and treatment of cancer
US10988516B2 (en) 2012-03-26 2021-04-27 Uti Limited Partnership Methods and compositions for treating inflammation
US8652999B1 (en) 2012-07-24 2014-02-18 Dow Agrosciences, Llc. Herbicidal compositions comprising 4-amino-3-chloro-5-fluoro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2-carboxylic acid or a derivative thereof and a sulfonylaminocarbonyltriazolinone
US9603948B2 (en) 2012-10-11 2017-03-28 Uti Limited Partnership Methods and compositions for treating multiple sclerosis and related disorders
GB201300684D0 (en) 2013-01-15 2013-02-27 Apitope Int Nv Peptide
RU2696876C2 (ru) 2013-11-04 2019-08-07 Ютиай Лимитед Партнершип Способы и композиции для устойчивой иммунотерапии
CN106030302B (zh) * 2013-12-12 2019-09-24 布里格姆妇女医院 治疗神经变性疾病
EP3090064B1 (en) 2013-12-31 2019-11-13 Yeda Research and Development Co. Ltd. Diagnosis of systemic lupus erythematosus using oligonucleotides antigens
US20160320384A1 (en) 2013-12-31 2016-11-03 Yeda Research And Development Co. Ltd. Methods for assaying immunological competence
WO2015148389A2 (en) * 2014-03-23 2015-10-01 The Regents Of The University Of Colorado Diagnosis of multiple sclerosis in human and animal subjects
EP2927687A1 (en) * 2014-03-31 2015-10-07 Ecole Polytechnique Federale de Lausanne (EPFL) Agents useful in diagnostic and therapy of beta-amyloid aggregation related disorders and screening methods
WO2015172008A1 (en) * 2014-05-09 2015-11-12 Multiple Sclerosis Research Center Of New York Transglutaminadase 6 as a biomarker for multiple sclerosis
WO2016123565A1 (en) 2015-01-30 2016-08-04 The Regents Of The University Of California N-acetyl glucosamine as a biomarker of ms disease course
EP3265814B1 (en) 2015-03-01 2020-11-18 Immunarray Ltd. Diagnosis of systemic lupus erythematosus using protein, peptide and oligonucleotide antigens
US20190060484A1 (en) 2015-05-06 2019-02-28 Uti Limited Partnership Nanoparticle compositions for sustained therapy
CN107043413A (zh) * 2016-02-05 2017-08-15 华中农业大学 一种肺结核相关的尿液生物标志蛋白及其应用
US11402379B2 (en) * 2016-09-09 2022-08-02 Mayo Foundation For Medical Education And Research Methods and materials for identifying and treating autoimmune GFAP astrocytopathy
US11793854B2 (en) 2019-03-21 2023-10-24 Op-T Llc Methods for reducing symptoms of multiple sclerosis using a six-amino acid long peptide that inhibits CD40-CD150 interaction
CN113336862B (zh) * 2021-07-05 2022-03-01 广东省科学院动物研究所 一种抗多发性硬化的重组蛋白及其制备方法和用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL137460A0 (en) * 2000-07-24 2001-07-24 Yeda Res & Dev Identifying antigen clusters for monitoring a global state of an immune system
DK1351707T3 (da) 2001-01-09 2011-07-11 Baylor Res Inst Fremgangsmåder til behandling af autoimmunsygdomme hos et individ og in vitro-diagnostiske analyser
US7785819B2 (en) 2001-04-10 2010-08-31 The Board Of Trustees Of The Leland Stanford Junior University Therapeutic and diagnostic uses of antibody specificity profiles
US20030092089A1 (en) 2001-11-14 2003-05-15 Moscarello Mario Anthony Method for diagnosing multiple sclerosis and an assay therefore
IL148401A0 (en) * 2002-02-26 2002-09-12 Hadasit Med Res Service Hsp70-derived peptides and uses thereof in the diagnosis and treatment of autoimmune diseases
AU2003282612A1 (en) * 2002-10-11 2004-05-04 The Regents Of The University Of California A method for diagnosis and prognosis of multiple sclerosis
US20050260770A1 (en) 2004-04-01 2005-11-24 Cohen Irun R Antigen array and diagnostic uses thereof
AU2005259726A1 (en) * 2004-07-01 2006-01-12 Kobenhavns Universitet Method for multiple sclerosis treatment and prophylaxis by treatment of Leptospira infection
EP1841887A2 (en) 2005-01-19 2007-10-10 Bayer Schering Pharma Aktiengesellschaft Cx3cr1 as a marker which correlates with both disease and disease activity in multiple sclerosis patients
US7572592B2 (en) * 2005-01-31 2009-08-11 Glycominds Ltd Method for diagnosing multiple sclerosis
EP1848743A2 (en) * 2005-02-14 2007-10-31 Wyeth Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor
WO2006116155A2 (en) * 2005-04-21 2006-11-02 The Regents Of The University Of California A method for diagnosis and prognosis of multiple sclerosis subtypes
WO2007014001A2 (en) * 2005-07-21 2007-02-01 The Board Of Trustees Of The Leland Stanford Junior University Multiplex determination of lipid specific binding moieties
WO2007056332A2 (en) 2005-11-07 2007-05-18 Vanderbilt University Molecular diagnosis of autoimmune diseases
WO2007137410A1 (en) 2006-05-26 2007-12-06 Phenomenome Discoveries Inc. Biomarkers for diagnosing multiple sclerosis, and methods thereof
EP2579038B1 (en) * 2007-04-12 2014-10-01 Universiteit Hasselt Biomarkers for multiple sclerosis

Also Published As

Publication number Publication date
CA2743590A1 (en) 2010-05-20
CN102388307A (zh) 2012-03-21
CN102388307B (zh) 2014-09-03
WO2010055510A3 (en) 2010-09-16
US9267945B2 (en) 2016-02-23
US20120077686A1 (en) 2012-03-29
WO2010055510A2 (en) 2010-05-20
JP2012508865A (ja) 2012-04-12
AU2009315230A1 (en) 2010-05-20
EP2353004A4 (en) 2012-04-18
EP2353004A2 (en) 2011-08-10
EP2353004B1 (en) 2018-01-03

Similar Documents

Publication Publication Date Title
HK1168423A1 (zh) 多發性硬化的診斷
GB2473392B (en) Methods of diagnosis
EP2255730A4 (en) ULTRASOUND
EP2263545A4 (en) ultrasonograph
GB0812712D0 (en) Improved endoscope
GB0809037D0 (en) Video Probe
PL390236A1 (pl) Biomarkery stwardnienia rozsianego
PL2111555T3 (pl) Diagnostyka stanu przedrzucawkowego
ZA201102604B (en) Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
GB0922006D0 (en) Diagnostic
PL2133419T3 (pl) Zastosowania beta-dipeptydów cyjanoficyny
GB0814533D0 (en) Measurement of bio-signals
EP2393933A4 (en) RNA AND DNA COPIERING ENZYMES
HK1160925A1 (zh) 組織蛋白酶 的用途
GB0816459D0 (en) State of change estimate
EP2311472A4 (en) AGENT FOR THE IMPROVEMENT OF COGNITIVE DISORDERS
AU322206S (en) Monitor
GB0809761D0 (en) Diagnosis of mycobacterial infections
EP2126564A4 (en) DIAGNOSTIC PROCEDURE
HK1131039A1 (en) Pharmaceutical use of sophoricoside
HUP1100131A3 (en) Diagnosis of systemic diseases
EP2331490A4 (en) PREPARATION OF DIBUTOXYMETHANE
GB0903858D0 (en) Diagnosis of disease
IL212859A0 (en) Diagnosis of multiple sclerosis
EP2079357A4 (en) DIAGNOSIS OF CARIES

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20181117